Menu
Back to Journals » Journal of Blood Medicine » Volume 4
Biomarkers for the differentiation of anemia and their clinical usefulness
Authors Northrop-Clewes CA, Thurnham DI
Received 17 October 2012
Accepted for publication 13 December 2012
Published 20 March 2013 Volume 2013:4 Pages 11—22
DOI https://doi.org/10.2147/JBM.S29212
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Christine A Northrop-Clewes,1 David I Thurnham2
1Nutrition Consultant, Cambridge, UK; 2Northern Ireland Centre for Food and Health, School of Biomedical Sciences, University of Ulster, Coleraine, UK
Abstract: The World Health Organization defines anemia as the point at which the amount of hemoglobin in the circulation falls below World Health Organization cutoffs for specific age and sex groups. Anemia is a worldwide problem of complex etiology and is associated with many factors. The purpose of this review was to describe the biomarkers used to identify the nature of anemia in patients and in the community. The important biomarkers are the automated red cell counts, tests for nutritional deficiencies, hemoglobinopathies, and inflammation. Diseases are important potential initiators of anemia, but biomarkers of specific diseases are not included in this review, only the underlying feature common to all disease – namely, inflammation.
Keywords: iron deficiency, biological markers, blood cell count, inflammation, avitaminosis, hemoglobinopathies
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.